Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by ONWARD Medical NV
ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights
May 23, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication
May 21, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
Nature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC-EX® Therapy
May 20, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Medical Schedules Webcast to Provide Q1 2024 Business Update
May 14, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions
May 02, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
April 25, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Medical Announces Publication of Full Year 2023 Financial Results and Business Update Webcast
April 11, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00
April 09, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System
April 02, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Medical Publishes Closing of Accelerated Bookbuild Offering and Public Offering in France
March 25, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Medical Publishes Prospectus for Listing of New Shares
March 21, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Medical Successfully Raises €20 Million in a Capital Increase by Way of an Accelerated Bookbuild Offering and by Way of a Public Offering in France
March 20, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Public Offering in France for an Indicative Amount of EUR 15 Million, with an Up to EUR 5 Million Upsize Option
March 20, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Medical Successfully Completes Benchmark Testing on Path to Commercialize ARC-EX® System
March 18, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Medical Reaffirms Guidance, Shares 2024 Strategic Priorities, and Releases Unaudited Q4 Financial Highlights
March 15, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System
March 11, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Medical Awarded 10th Breakthrough Device Designation for Brain-Computer Interface (BCI) from US FDA
February 29, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
KBC Securities Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 10.00 Per Share
February 09, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® MEDICAL ANNOUNCES PRESENTATION AT BIOCAPITAL EUROPE
February 07, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® ARC Therapy™ Highlighted at 2024 Annual Meeting of the North American Neuromodulation Society (NANS)
January 25, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® to Participate in Basel Healthtech Conference 2024
January 22, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® to Participate in Degroof Petercam Healthcare Conference
January 19, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Announces Start of HemON NL Clinical Study
January 18, 2024
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Reports Q3 Business Update and Year-To-Date Highlights
November 16, 2023
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD Schedules Webcast to Provide Third Quarter 2023 Business Update
October 11, 2023
From
ONWARD Medical NV
Via
GlobeNewswire
ONWARD® Announces First-in-Human Implant of ARC-IM™ Stimulator with Brain-Computer Interface (BCI) to Restore Arm, Hand, and Finger Function after Spinal Cord Injury
September 27, 2023
From
ONWARD Medical NV
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.